TNS Healthcare launches DetailMed

Share this article:
TNS Healthcare has unveiled a call assessment tool measuring detail effectiveness across countries, brands and categories. According to a company statement, DetailMed is tracked continuously online, and allows users to monitor the quality of their own sales calls, as well as competitors' detailing. 
“DetailMed is the first continuous call assessment tool built to support global brands. With DetailMed, pharmaceutical companies finally have a solution that lets them measure message impact and call quality across countries—a strategic necessity for fully understanding and optimizing brand performance,” said David Owen, director at TNS Healthcare, in a statement.

Info gathered by DetailMed is presented through an online dashboard, a type of user interface increasingly used for tracking ROI. Users can customize the service by choosing the geographic level, frequency of results or specific physicians. 
Share this article:
You must be a registered member of MMM to post a comment.
close

Next Article in Features

Email Newsletters

MM&M EBOOK: PATIENT ACCESS

Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in Features

Read the complete September 2014 Digital Edition

Read the complete September 2014 Digital Edition

Click the above link to access the complete Digital Edition of the August 2014 issue of MM&M, with all text, charts and pictures.

Medical marketing needs mainstream Mad Men

Medical marketing needs mainstream Mad Men

Agencies must generate emotional resonance with the target audience, not unlike Apple, Pepsi or Nike

Are discounts cutting out co-pays?

GSK's decision to cut Advair's price spurred some PBMs to put it back on formulary. Will drugmaker discounts diminish the need for loyalty programs? How can these programs stay relevant beyond giving co-pay assistance?